Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunome Inc.

8.85
-0.0100-0.11%
Post-market: 8.850.00000.00%16:01 EDT
Volume:549.62K
Turnover:4.92M
Market Cap:769.51M
PE:-1.77
High:9.16
Open:8.92
Low:8.85
Close:8.86
Loading ...
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Major Issues Report

8-K - Current report
Jan 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 29, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 18, 2021

Major Issues Report

8-K - Current report
Oct 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 21, 2021

Major Issues Report

8-K - Current report
Sep 08, 2021

Major Issues Report

8-K - Current report
Aug 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals